Evidence and controversies on impact of HPV infection on OPC

• HN 04-01 • Influence of HPV on transformation Pro > A. Amanda PSYRRI • HN 04-02 • Influence of HPV on transformation Con See abstract > C. Carolin GÖTZ • HN 04-03 • Detection of HPV, a criterion for therapeutic decision? Pro > J. Jean LACAU ST. GUILY • HN 04-04 • Detection of HPV, a criterion for therapeutic decision? Con > A. Andreas KOLK • HN 04-05 • Use of oral HPV infection or blood bio-markers for early identification of recurrence Pro > H. Haïtham MIRGHANI • HN 04-06 • Use of oral HPV infection or blood bio-markers for early identification of recurrence Con > M. Magnus VON KNEBEL DOEBERITZ • HN 04-07 • Microbiote associated with oral cancer, a diagnostic-prognostic marker? See abstract > J. Jaana RAUTAVA • HN 04-08 • The value of p16ink4a as a surrogate marker > R. Ruud BRAKENHOFF • HN 04-09 • The role of serological markers See abstract > T. Tim WATERBOER • INT1 • Conclusion: validation and standardization perspective